A Phase 3 Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

• Status: Completed
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total knee arthroplasty.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daiichi Sankyo Co., Ltd.
• Treatments: Edoxaban; Enoxaparin; Enoxaparin sodium

Criteria

Inclusion Criteria:

• Patients undergoing unilateral total knee arthroplasty

Exclusion Criteria:

• Subjects with risks of hemorrhage

• Subjects with thromboembolic risks

• Subjects who weigh less than 40 kg

• Subjects who are pregnant or suspect pregnancy, or subjects who want to become pregnant.